Communicating value in health care using radar charts: A case study of prostate cancer

Journal of Oncology Practice

Volumn 12, Issue 9, 2016, Pages 813-820

  Thaker, Nikhil G ^a   Ali, Tariq N ^a   Porter, Michael E ^a   Feeley, Thomas W ^a   Kaplan, Robert S ^a   Frank, Steven J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER TEST; CANCER THERAPY; COST; ENTEROPATHY; HEALTH CARE; HUMAN; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT PREFERENCE; PATIENT-REPORTED OUTCOME; PROSTATE CANCER; PROSTATECTOMY; PROTON THERAPY; RADIATION DOSE; RETROSPECTIVE STUDY; ROBOT ASSISTED SURGERY; SEXUAL FUNCTION; TELECOMMUNICATION; TREATMENT OUTCOME; URINE INCONTINENCE; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE COST; METHODOLOGY; PROSTATIC NEOPLASMS; QUALITY OF LIFE;

BRACHYTHERAPY; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; MALE; PATIENT REPORTED OUTCOME MEASURES; PROSTATECTOMY; PROSTATIC NEOPLASMS; PROTON THERAPY; QUALITY OF LIFE; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 84987600841     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2016.011320     Document Type: Article

References (19)

1. Porter ME: Value-based health care delivery. Ann Surg 248:503-509, 2008
2. Porter ME: What is value in health care? N Engl J Med 363:2477-2481, 2010
3. Skinner D: Defining medical necessity under the Patient Protection and Affordable Care Act. Public Adm Rev 73:S49-S59, 2013
4. US Department of Health and Human Services: Better, Smarter, Healthier: In historic announcement, HHS sets clear goals and timeline for shifting Medicare reimbursements from volume to value. http://www.hhs.gov/news/press/2015pres/01/20150126a.html
5. Porter ME: A strategy for health care reform-Toward a value-based system. N Engl J Med 361:109-112, 2009
6. Porter ME, Teisberg EO: Redefining competition in health care. Harv Bus Rev 82: 64-76, 136, 2004
7. Porter ME, Teisberg EO: Redefining Health Care. Boston, MA, Harvard Business School Press, 2006
8. Martin NE, Massey L, Stowell C, et al: Defining a standard set of patient-centered outcomes for men with localized prostate cancer. Eur Urol 67:460-467, 2015
9. Nguyen PL, Gu X, Lipsitz SR, et al: Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol 29:1517-1524, 2011
10. Cooperberg MR, Ramakrishna NR, Duff SB, et al: Primary treatments for clinically localised prostate cancer: A comprehensive lifetime cost-utility analysis. BJU Int 111:437-450, 2013
11. Woodward RM, Menzin J, Neumann PJ: Quality-adjusted life years in cancer: Pros, cons, and alternatives. Eur J Cancer Care (Engl) 22:12-19, 2013
12. French K, Albright H, Frenzel J, et al: Measuring the value of process improvement initiatives in a preoperative assessment center using time-driven activity based costing. Healthc (Amst) 1:136-142, 2013
13. Kaplan RS, Witkowski M, Abbott M, et al: Using time-driven activity-based costing to identify value improvement opportunities in healthcare. J Healthc Manag 59:399-412, 2014
14. Kaplan RS, Anderson SR: Time-driven activity-based costing. Harv Bus Rev 82: 131-138, 150, 2004
15. Kaplan RS, Porter ME: How to solve the cost crisis in health care. Harv Bus Rev 89:46-52, 54, 56-61 passim, 2011
16. Thaker N, Guzman A, Feeley T, et al: Defining the value of proton therapy in an evolving healthcare system using time-driven activity-based costing. Oncology Payers, Policy Makers, and Prescribers 1:22-28, 2014
17. Thaker NG, Frank SJ, Feeley TW: Comparative costs of advanced proton and photon radiation therapies: lessons from time-driven activity-based costing in head and neck cancer. J Comp Eff Res 4:297-301, 2015
18. Ciezki J, Reddy C, Angermeier K, et al: Long-term toxicity and associated cost of initial treatment and subsequent toxicity-related intervention for patients treated with prostatectomy, external beam radiotherapy, or brachytherapy: A SEER/Medicare database study. J Clin Oncol 30, 2012 (suppl 5, abstr 4)
19. Pugh TJ, Munsell MF, Choi S, et al: Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 87:946-953, 2013